Your Article Summary
Merck eyes deals, growth through 2013
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Merck & Co Inc's CEO sees profit growth from 2010 to 2013 despite looming generic competition for two of its biggest drugs, and has the appetite to buy a big biotechnology company if the right deal comes along.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
What Makes a Generic Medication Generic?
Journal of Psychosocial Nursing and Mental Health Services, 12/18/09
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Article Search
Sponsor


See Latest Articles


